

(Alliance News) - AstraZeneca PLC on Thursday said US regulators have approved its drug Koselugo for use in adults with neurofibromatosis type 1, expa...


(Sharecast News) - The US Food and Drug Administration has approved the expanded usage of AstraZeneca's Koselugo drug to adults with neurofibromatosis...


FTSE 100 fall 0.5%, FTSE 250 ends flat *


BOSTON, Nov 18 (Reuters) - U.S. prosecutors on Tuesday unveiled charges against eight men accused of belonging to a global network that made tens of...


FRANKFURT, Nov 18 (Reuters) - Roche's experimental oral drug giredestrant has been shown to cut the risk of recurrence of a common form of breast ca...


(Alliance News) - Stock prices in Europe opened in the red on Tuesday, following sharp falls in Asia and as equities in New York struggled overnight, ...


(Alliance News) - Stocks fell and bonds yields spiked in volatile trading on Friday amid uncertainty over UK budget proposals after an apparent u-turn...


(Sharecast News) - London-listed companies 3i Group and AstraZeneca disclosed fresh director dealings on Wednesday, with senior executives at the priv...